Recommendations for the management and treatment of ankylosing spondylitis.

Item

http://www.wikidata.org/entity/Q44898441

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Recommendations for the management and treatment of ankylosing spondylitis.

@en

Recommendations for the management and treatment of ankylosing spondylitis.

@nl

type

Item

label

Recommendations for the management and treatment of ankylosing spondylitis.

@en

Recommendations for the management and treatment of ankylosing spondylitis.

@nl

prefLabel

Recommendations for the management and treatment of ankylosing spondylitis.

@en

Recommendations for the management and treatment of ankylosing spondylitis.

@nl

P1476

Recommendations for the management and treatment of ankylosing spondylitis.

@en

P2093

Antonio Carlos Ximenes

http://www.w3.org/2001/XMLSchema#string

Célio Roberto Gonçalves

http://www.w3.org/2001/XMLSchema#string

Eduardo de Souza Meirelles

http://www.w3.org/2001/XMLSchema#string

Marcelo de Medeiros Pinheiro

http://www.w3.org/2001/XMLSchema#string

Mauro Keiserman

http://www.w3.org/2001/XMLSchema#string

Roberto Ranza

http://www.w3.org/2001/XMLSchema#string

Rubens Bonfiglioli

http://www.w3.org/2001/XMLSchema#string

Spondyloarthritis Commision of the Brazilian Society of Rheumatology

http://www.w3.org/2001/XMLSchema#string

Sueli Carneiro

http://www.w3.org/2001/XMLSchema#string

Valderílio Feijó Azevedo

http://www.w3.org/2001/XMLSchema#string

P2860

Physical function, disease activity, and health-related quality-of-life outcomes after 3 years of adalimumab treatment in patients with ankylosing spondylitis

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

Undifferentiated spondyloarthritis: a longterm followup

Effectiveness of switching between TNF inhibitors in ankylosing spondylitis: data from the NOR-DMARD register.

Longitudinal numbers-needed-to-treat (NNT) for achieving various levels of analgesic response and improvement with etoricoxib, naproxen, and placebo in ankylosing spondylitis.

Frequency and duration of drug-free remission after 1 year of treatment with etanercept versus sulfasalazine in early axial spondyloarthritis: 2 year data of the ESTHER trial.

Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled study.

Efficacy of etanercept on rheumatic signs and pulmonary function tests in advanced ankylosing spondylitis: results of a randomised double-blind placebo-controlled study (SPINE).

Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis.

Impact of anti-tumour necrosis factor alpha treatment on admissions to hospital and days of sick leave in patients with ankylosing spondylitis

P2888

s0482-50042013000300003

P304

242-257

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1590/S0482-50042013000300003

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Percival D Sampaio-Barros

P577

2013-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1038750062

http://www.w3.org/2001/XMLSchema#string

P698

24051908

http://www.w3.org/2001/XMLSchema#string